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Abstract:  
Immunogenicity arises via many synergistic mechanisms, yet the overall dissimilarity of pathogenic proteins versus the host proteome has been proposed 
as a key arbiter. We have previously explored this concept in relation to Bacterial antigens; here we extend our analysis to antigens of viral and fungal 
origin. Sets of known viral and fungal antigenic and non-antigenic protein sequences were compared to human and mouse proteomes. Both antigenic and 
non-antigenic sequences lacked human or mouse homologues. Observed distributions were compared using the non-parametric Mann-Whitney test. The 
statistical null hypothesis was accepted, indicating that antigen and non-antigens did not differ significantly. Likewise, we could not determine a threshold 
able meaningfully to separate non-antigen from antigen. We conclude that viral and fungal antigens cannot be predicted from pathogen genomes based 
solely on their dissimilarity to mammalian genomes. 
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Background: 
Immunogenicity manifests itself through both humoral (mediated through 
the binding of whole protein antigens by antibodies) and cellular 
immunology (mediated by the recognition of proteolytically cleaved 
peptides by T-cells). Mechanistically, protein immunogenicity arises from 
many synergistic factors. These include host-side properties and pathogen-
side properties. Properties mediated by the host include the density of T-
cell or B-cell epitopes and how easily it is degraded; while pathogen 
mediated properties include protein expression levels and sub-cellular 
location. Thus a viable candidate vaccine should be highly expressed, 
available for immune surveillance, and possess epitopes that the host 
recognises. Other properties, mostly intrinsic to the protein, include 
molecular size, aggregation status, and possession of so-called danger-
signals, typically chemical modifications, post-translational in origin, 
which are recognised by pattern recognition receptors of the innate 
immune system. An alternative hypothesis replaces such complexity with 
the simple, straightforward idea of phylogenetic distance as the chief 
determinant of immunogenicity. This notion finds its most eloquent 
advocate in the work of Kundac et al. [1]. In previous work [2], we have 
examined a restated variant of this concept: that non-redundancy at the 
sequence level is crucial to the accurate prediction of antigen-based 
candidate vaccine antigens. When examining bacterial antigens, both 
antigens and non-antigens lacked equally similarity to host proteomes. 
Moreover, both were as dissimilar as the background distribution offered 
by a complete bacterial genome. We were unable to find an appropriate 
and useable threshold capable of differentiate antigens from non-antigens 
on the basis of similarity to the host’s proteome. In the present work, we 
extend our analysis of “immunogenicity as phylogenetic distance” to 
embrace the full scope of life, pushing to the limits of Woese’s three 
domains of life and beyond. As there is little or no evidence for archaea 
acting as pathogens, though some are implicated as commensals with 
pathogen-mediated disease, we look at two other kinds of widely 
phyletically distributed pathogenic organism, namely viruses and 
fungi.Viruses are structurally-simple, quasi-organisms that straddle the 
boundary between complex chemical entities and true living organisms. 
Most would agree that bacteria are alive yet a piece of DNA is not. Viruses 
give rise to diverse infections: for example, over 300 distinct viruses cause 
upper respiratory infections bracketed as the common cold, while others 
are responsible for diseases as different as chickenpox, influenza, HCV, 
and AIDS. Fungi are complex, eukaryotic organisms distinct from plants 
and animals. Some fungal species are very pathogenic, and can infect all 
exposed individuals, i.e. Coccidioides immitis and Histoplasma 
capsulatum. Others are opportunities pathogens, such as Candida 
Albicans, which give rise to disease only in immunocompromised hosts. 
Importantly both have very different mechanisms of pathogenesis when 
compared to each other and also to bacteria. Thus both are distinct, and 
distinct also from prokaryotic bacteria. Compared to viral infections, 
fungal diseases are less harmful but more tenacious. Fungi such as 
Candida typically colonise external and mucosal surfaces, such as the 
intestines. Overtly harmless, such fungi can induce local infections of the 
skin, nails, mouth, vagina, or sinuses: they are seldom serious, except in 
the immune deficient. Occasionally, infections occur when habitual 
suppression of fungi is disturbed. For example, bacteria found in the 
vagina or alimentary canal usually limits fungal growth. Antibiotics can 
kill such helpful bacteria, allowing fungi to grow unchecked, and thus 
cause symptoms, which are typically mild. Certain fungal infections, such 
as blastomycosis, may be more serious.By using the sequence similarity 
search tool BLAST [3], we expand our sequence similarity discrimination 
of non-antigen from antigen, again also seeking a value that can separate 
these classes. More specifically, we analysed the similarity between sets of 
known fungal and viral antigens and the Human Genome and Mouse 
Genome, compared with a control group of non-antigens, and likewise 
made an assessment versus the similarity evinced by a background 
distributions, namely fungal genomes and large sets of viral sequences. 
Our primary outcome establishes a systematic benchmark for the success 
of “immunogenicity as phylogenetic distance” as a concept useful in 
antigen hunting. 
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Methodology:  
Datasets of known antigens obtained previously from the literature were 
analysed [2, 4, 5, and 6]. Non-antigens were selected from SWISSPROT 
so that they mirrored the antigen sets, being selected at random from the 
same set of species [5, 6]. Fungal and Viral antigens used here are listed 
below in Figure 1. Additionally, genomes corresponding to Human, 
Mouse, and Fungus were downloaded from FTP sites at National Center 
for Biotechnology Information (NCBI) [http://www.ncbi.nlm.nih.gov/], 
European Bioinformatics Institute (EBI) [http://www.ebi.ac.uk/], and 
Ensembl [http://www.ensembl.org/]. Since viral genomes rarely exceed a 
few hundred sequences, and are thus of a comparable size to our datasets, 
we obtained a larger compilation of viral sequences from the Viral 
Bioinformatics Resource Center (http://www.biovirus.org/). All the peptide 
sequences obtained were in FASTA format. 
 
As before [2], antigen datasets, non-antigen datasets and various 
pathogenic genome sequences to the Human and Mouse Genome were 
analysed using a local, standalone version of BLAST [3], which afforded 
full management of E-value cut-offs. E-value thresholds were raised from 
10 to 6000 to identify best matches even when these lacked statistical 
significance. We also analysed (log10
E-value)+1 values obtained from 
BLAST. By using the statistical package Minitab, Release 14.1, we 
compared antigen and non-antigen sets, as random samples of two larger, 
independent populations, utilising a Mann–Whitney test. 
 
 
Figure 1: Protein sequences compiled and annotated in-house as fungal and viral antigens. 
 
 
Figure 2: Viral Sequence Comparison. A sequence similarity comparison with the E-value as 6000 and BLOSUM 62 matrix, between the Antigen, 
Non-antigen and viral genome sequences. Two separate scales were used as the number of matches to the Human Genome varied from the antigen and 
non-antigen datasets to the genome. The blue line with the star marker corresponding to the genome is plotted on the scale to the right hand axis (Y axis). Bioinformation  Volume 5 
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Figure 3: Fungal Sequence Comparison. A sequence similarity comparison with the E-value as 6000 and BLOSUM 62 matrix, between the Antigen, 
Non-antigen and Aspergillus fumigatus genome sequences. Two separate scales were used as the number of matches to the Human Genome varied from 
the antigen and non-antigen datasets to the genome. The blue line with the star marker represents the genome is plotted on the scale to the right hand axis 
(Y axis). 
 
Discussion: 
Following a protocol established earlier for analysing the similarity of 
bacterial and eukaryotic proteomes [2], sets of antigens and non-antigens 
from both fungi and viruses were compared to the Human and Mouse 
proteomes, producing lists of highest scoring similarities. Proteomes and 
pseudo-proteomes of fungal and viral origin were also compared to the 
human and mouse proteomes. Antigen sets derived from the literature 
contained 100 viral antigens and 33 fungal antigens respectively; similarly 
sized sets of non-antigens for the two types of pathogen were also 
obtained, selected at random from the same sets of species. 
 
Results obtained for viruses were even more extreme than those observed 
previously for bacteria [2]. For the case of viruses, apart from rare 
anomalies such as mimivirus, few available genomes contain more than a 
few hundred sequences, which is not sufficient to give a reference 
background to the analysis. Instead, we used a composite viral pseudo-
genome comprising sequences from many viral species. Score histograms 
for antigen and non-antigen sets, and the viral pseudo-proteome, versus the 
human proteome are shown in Figure 2. Overall, viral antigens show no 
overt similarity to the human or mouse genomes. All the protein sequences 
were found to be in the range of 0 to 10 when compared the human 
proteome, while comparison to the mouse proteome yielded sequences 
with values between -10 to 10, indicating high dissimilarity of viral 
antigens compared to host proteomes. Values for non-antigenic protein 
sequences were found to lie between -40 to 10 when compared to human 
and mouse proteomes. Only 2 non-antigenic protein sequences were less 
than -40. Again, any signal here is too weak to stand as a useful threshold. 
 
Results obtained for fungal antigens and non-antigens were very similar to 
those obtained for Bacteria and viruses, despite the smaller sample size. 
This reduced prevalence reflects the small number of known fungal 
antigens available at the time of the study. A similar analysis for four 
fungal proteomes (Aspergillus fumigatus, Candida albicans, 
Encephalitozoon cuniculi and Saccharomyces cerevisiae) versus Human 
and Mouse proteomes was also undertaken. All sets analysed were 
similarly distant to both mouse and human genomes. Score histograms for 
antigen and non-antigen sets, and the Aspergillus fumigatus proteome 
versus the human proteome are shown in Figure 3. It is clear that the three 
distributions strongly overlap, and that no clear cut-off point presents 
itself. However, we did observe five fungal antigens with high similarity to 
human and mouse proteomes. These proteins were characteristically 
highly-conserved over evolution, such as enzymes or heat shock proteins. 
Looked at overall, the observed ranges of score (–70 and 10 for antigens 
versus -80 to 10 for non-antigens) could not be easily differentiated thus 
stymieing attempts to use this as a tool for predicting whole-protein 
antigens. 
 
We also used statistical significance testing to quantify the commonality 
between observed score distributions. Since our distributions were not 
normally distributed, we used the straightforward, non-parametric Mann–
Whitney Test for this assessment, since it is more robust for skewed 
distributions such as these, rather than using, say, the 2 sample 
Kolmogorov-Smirnov test to compare distributions. The Mann-Whitney 
test was undertaken at the 95% confidence interval. The p-value for 
comparison of the viral distributions was 0.322. The corresponding p-value 
for fungal sequences was 0.381. As the p-value was greater than 0.05 in 
both cases, the null hypothesis was accepted for both viruses and fungi. 
Note that the p-value for the bacterial comparison [2] was 0.239. Thus 
there was no statistically significant difference in any of the three cases. 
 
We cannot use these values to determine a reliable threshold able to 
distinguish antigen from non-antigen when compared to against the 
background distribution for whole genomes: what difference there is 
statistically insignificant. BLAST is seen by many as very much a blunt 
instrument, particularly for the fine-detail analysis of large and/or complex 
protein families. Even if a wholly correct and validated match can be 
discovered, BLAST can struggle to distinguish orthologues from 
paralogues. Future work could thus include more sophisticated approaches 
to quantifying sequence similarity beyond that offered by BLAST. 
 
Conclusion: 
Despite the negative outcomes observed in this study, which though 
disappointing are not altogether unexpected, given prior results [2], there is 
still an urgent and pressing need for the development of robust techniques 
for the identification of whole protein antigens. The problem is not that 
bacterial or viral or fungal proteins are not clearly different from the 
human genome: indeed they are. No, for both fungi and viruses, the 
problem is that antigens and non-antigens are different to the same degree; 
as with bacteria [2], we cannot calibrate a useful threshold able to separate 
them. 
 
Lack of transparent variation in measured similarity and the inability to 
locate thresholds that split positives from negatives is by no means unique 
to the present problem. An illuminating example is chemical similarity 
searching [7]. Bit-string representations of molecular structure have long 
been applied to small molecule similarity searching. Despite the simplicity 
of the approach, such bit-string patterns have been unexpectedly 
successful. Yet, we currently have no generally applicable similarity Bioinformation  Volume 5 
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metrics and structural similarity thresholds able to indicate reliably 
equivalent biological activity.  
 
It is an old maxim in management consultancy that 20% of the total effort 
generates 80% of the total result; how true this assertion is, in quantitative 
terms, we leave to your discretion, yet the sentiment it embodies carries 
with it much sagacity. Our current results show the inadequacy of this 
approach, despite the gallimaufry of countervailing caveats of which one 
could conceive to counter this conjecture. The clear lack of a signal 
apparent here is not likely to be modulated much by fiddling round with 
parameters or even using different but similar approaches. 
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